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Abstract: OBJECTIVE To determine if MRI findings prior to intra-articular corticosteroid hip infiltra-
tion are related to treatment outcomes. METHODS This prospective outcome study with retrospective
MRI evaluation includes 100 consecutive patients with MRI within 6 months before a therapeutic intra-
articular hip injection. Labrum, bone marrow, acetabular and femoral cartilage abnormalities were
assessed by two radiologists blinded to patient outcomes: the proportion reporting ”improvement” on
the Patient’s Global Impression of Change (PGIC) scale at 1 day, 1 week and 1 month follow-up were
compared based on MRI findings using ฀2. The t-test was used to compare pain change scores with MRI
abnormalities. RESULTS Patients with a normal labrum in the posterosuperior quadrant were more
likely to report PGIC ”improvement” at 1 week compared to labral degeneration (p = 0.048). Significant
differences in pain change scores were found at all time points for the labral anteroinferior quadrant (p
= 0.001, 1 day; p = 0.010, 1 week; p = 0.034, 1 month) with the highest reduction in patients with
labral degeneration. Females were 2.80 times more likely to report clinically relevant ”improvement” at
1 day (p = .049) and 2.90 times more likely to report clinically relevant ”improvement” at 1 month (p =
.045). CONCLUSION Cartilage defects and marrow abnormalities were not associated with outcomes.
Patients with a normal labrum in the posterosuperior quadrant had better outcomes at 1 week. Patients
with labral degeneration of the anteroinferior quadrant had higher levels of pain reduction at all time
points. Females were significantly more likely to report PGIC ”improvement”. ADVANCES IN KNOWL-
EDGE A significant treatment outcome was observed amongst gender, although there were no significant
differences in the MRI findings.
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IntroDuctIon
Intra- articular corticosteroid injections are widely used for 
the treatment of knee and hip osteoarthritis (OA).1,2 Studies 
have shown that corticosteroid injections into the hip artic-
ulation in OA patients are related to short- term pain reduc-
tion, irrespective of the arthritis severity.1,2 Several authors 
have compared the effects of intra- articular corticosteroid 
injections with injections of either hyaluronic acid, analge-
sics or placebo on patients with hip OA, showing signifi-
cantly better efficacy of corticosteroid compared to placebo 
or analgesic injections.3–5
A variety of possible anatomical correlates have been 
reported in patients with hip pain. Hip OA patients often 
have labral tears. However, labral defects are often asymp-
tomatic and common in most patients above age 70.6 A 
retrospective study on hip arthroscopy patients observed 
greater pain relief in patients with both labral and chon-
dral defects than in patients without cartilage pathology.6 
It has been proposed that a possible source of pain caused 
by hip OA could be the stimulation/irritation of pain fibers 
in the cartilage.7 The development of bone marrow edema 
following cartilage defects has been described by numerous 
studies for the knee joint,8–10 and also occurs in hip OA.8
Several studies have sought to identify predictors of a 
good response to intra- articular corticosteroid injections. 
In their study on knee OA patients, Jones et al11 could not 
determine clinical predictors for a positive response. Plant 
et al12 observed a short- term improvement of the pain in 
both OA and rheumatoid arthritis of the hip, but inde-
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objective: To determine if MRI findings prior to intra- 
articular corticosteroid hip infiltration are related to 
treatment outcomes.
Methods: This prospective outcome study with retro-
spective MRI evaluation includes 100 consecutive 
patients with MRI within 6 months before a ther-
apeutic intra- articular hip injection. Labrum, bone 
marrow, acetabular and femoral cartilage abnormalities 
were assessed by two radiologists blinded to patient 
outcomes: the proportion reporting "improvement" on 
the Patient’s Global Impression of Change (PGIC) scale 
at 1 day, 1 week and 1 month follow- up were compared 
based on MRI findings using χ2. The t- test was used to 
compare pain change scores with MRI abnormalities.
results: Patients with a normal labrum in the postero-
superior quadrant were more likely to report PGIC 
"improvement" at 1 week compared to labral degenera-
tion (p = 0.048). Significant differences in pain change 
scores were found at all time points for the labral antero-
inferior quadrant (p = 0.001, 1 day; p = 0.010, 1 week; p 
= 0.034, 1 month) with the highest reduction in patients 
with labral degeneration. Females were 2.80 times more 
likely to report clinically relevant "improvement" at 1 day 
(p = .049) and 2.90 times more likely to report clinically 
relevant "improvement" at 1 month (p = .045).
conclusion: Cartilage defects and marrow abnormali-
ties were not associated with outcomes. Patients with 
a normal labrum in the posterosuperior quadrant had 
better outcomes at 1 week. Patients with labral degen-
eration of the anteroinferior quadrant had higher levels 
of pain reduction at all time points. Females were signifi-
cantly more likely to report PGIC "improvement"
advances in knowledge: A significant treatment 
outcome was observed amongst gender, although there 
were no significant differences in the MRI findings.
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our knowledge, no data have been published on the relationship 
of MRI- findings before an intra- articular infiltration of the hip 
joint and patient treatment outcomes.
Therefore, the purpose of this study was to assess whether the 
abnormal findings seen on MRI prior to injection are related to 
the outcomes of imaging- guided therapeutic hip injections over 
1 month.
MetHoDs anD MaterIals
Study design and patient population
This hip cohort outcome study was conducted at a specialized 
Orthopaedic University Hospital. A total of 100 consecutive 
patients referred to the radiology department who met the 
inclusion criteria, received an imaging- guided therapeutic hip 
injection, provided baseline pain level data and answered two 
outcome measures at 1 day, 1 week and 1 month follow- up (FU) 
were included. These patients were part of the large database of 
therapeutic injections outcomes collected prospectively by the 
radiology department between November 2009 and September 
2015 and were all treated for primary OA. No other additional 
treatments than the intra- articular injection were offered. 
Patients had to meet the following inclusion criteria: (a) be at 
least 40 years old; (b) have an intra- articular injection of one hip; 
(c) had a non- contrast MRI or MR arthrography of the relevant 
hip acquired no longer than 6 months prior to injection; (d) be 
able to read and understand the questionnaires (in German); (e) 
answer all baseline and FU questionnaires. Exclusion criteria 
were: (a) diagnostic imaging evidence of femoroacetabular 
impingement (a consensus reading by two musculoskeletal 
radiologists), (b) hip- prosthesis or previous surgery of the hip 
joint, (c) extra- articular injections (trochanteric bursa or ilio-
psoas tendon). Ethics approval was obtained from the hospital 
and county ethics committees (EK 12/2009). Informed consent 
was obtained before the injection.
MRI protocols
The conventional MRI scans as well as the MR arthrograms were 
done using a 1.5 T system (Avanto or Espree, Siemens Health-
care, Erlangen, Germany) using a flexible four- channel body 
matrix phased- array surface coil and a six- channel spine matrix 
coil integrated into the examination table and included a single 
hip. As a standard, secondary radial reformations are performed 
in all patients, based on the three- dimensional transverse oblique 
water- excitation true fast imaging with steady- state precession 
(FISP) sequence. Details of the specific sequences are shown in 
Table 1.
Data collection and imaging reading
The MRI examinations acquired prior to the injection were 
read retrospectively in consensus and blinded to the treatment 
outcomes by two musculoskeletal radiologists having respec-
tively 12 and 14 years of expertise in this field. Included were 
unilateral MRI examinations without (non- contrast MRI) (N = 
33) or with (MR arthrography) intra- articular contrast agent of 
the hip joint (N = 67), which were performed within 6 months 
prior to the therapeutic injection. Three groups of anatomical 
structures (labrum, bone marrow and cartilage) were evalu-
ated. The hip articulation was anatomically divided into four 
quadrants (anterosuperior, anteroinferior, posterosuperior and 
posteroinferior) (Figure  1).13 For each quadrant, the following 
subclassification of findings was performed: for the labrum, the 
presence of (1) labral degeneration, (2) labral tear (Figure  2), 
or (3) the combination of labral degeneration and tear was 
recorded. For bone marrow abnormalities, the presence of (1) 
bone marrow edema, (2) a subchondral cyst (Figure  3) or (3) 




















to long axis of 
femoral neck) 
water- excitation 
true fast imaging 
with steady- state 
precession (FISP) 
sequence
TR/TE 527/14 3520/39 25.2/8.6 550/13 11.7/5.2
Flip angle 150° 150° 25° 180° 28°
Section thickness 3 mm 3 mm 1.7 mm 4 mm 1.25 mm
Intersection gap 0.6 mm 0.6 mm None 0.8 mm None
FOV 18 cm 18 cm 16 cm 18 cm 17 cm
Matrix 384 × 269 320 × 320 384 × 256 320 × 256 384 × 256
Turbo factor 2 - - 2 -
Number of signals 
acquired
2 1 1 2 2
3D, three- dimensional; FOV, field of view; TR/TE, repetition time/echo time; cm, centimeters; mm, millimeters.
3 of 10 birpublications.org/bjr Br J Radiol;93:20190817
BJRA prospective outcome study
both bone marrow edema and a subchondral cyst was recorded. 
The acetabular and femoral cartilages were assessed separately, 
and pathological findings were graded by the presence of damage 
leading to (1) ≤50% thickness or (2) >50% thickness substance 
defect of the cartilage (Figure 4). Finally, for all three structures, 
absence of the designated abnormal finding gave the grade of 0.
Imaging-guided therapeutic injection protocol
The therapeutic injections were performed at this hospital by 
experienced radiologists under sterile conditions (three times 
disinfection of the skin, sterile gloves, mask and drapes). First, 
an injection of contrast agent (2 ml Iopamidol (IOPAMIRO 
200 mg ml−1; Bracco Suisse SA, Manno, Switzerland)) was 
performed in the hip joint under fluoroscopic guidance in order 
to control the positioning of the 21G- needle. Then the patient 
received an injection of a local anesthetic (5 ml of 2% Lidocain 
hydrochloride (RAPIDOCAIN 2%; Sintetica SA, Mendrisio, 
Switzerland)), followed by 1 ml of corticosteroid (1 ml Triam-
cinolone acetonide (TRIAMCORT 40 mg ml−1; Helvepharm AG, 
Frauenfeld, Switzerland)) (Figure 5). All patients received injec-
tions containing only corticosteroid and anesthetic.
Assessment of patient outcomes
The assessment of over all treatment outcome, collected prospec-
tively, was performed using the Patient's Global Impression of 
Change for overall improvement (PGIC) (primary outcome 
measure) and the Numerical Rating Scale for pain (NRS) 
(Figure 6), which have been established since 2009 as in- house 
questionnaires to collect the outcomes for imaging- guided 
Figure 1. Sagittal MRI slice showing the four quadrants of the 
hip for analysis.
Figure 2. Transverse T2W MR arthrogram in a 44- year- old 
female showing a posterior labral tear in the hip joint. T2W, 
T2 weighted.
Figure 3. Transverse T2W MR arthrogram in a 70- year- old 
female showing acetabular and femoral cysts in the hip joint, 
severe cartilage loss and subtle bone marrow edema pat-
tern.T2W, T2 weighted.
Figure 4. Sagittal T2W MR arthrogram in a 43- year- old female 
showing acetabular cartilage delamination in the hip joint as 
well as multiple subchondral cysts and full thickness cartilage 
loss. T2W, T2 weighted.
4 of 10 birpublications.org/bjr Br J Radiol;93:20190817
BJR  Pochon et al
therapeutic injections and were described in previous studies 
as “the most valid, reliable, and time- effective outcome 
measures.”14,15
The PGIC is a 7- point scale including the responses "much better," 
"better," "slightly better," "unchanged," "slightly worse," "worse" 
and "much worse." This scale includes the subjective improve-
ment in terms of activity limitations, symptoms, emotions 
and overall quality of life. The PGIC scale was the primary 
outcome measure and was dichotomized into "improved" or 
"not improved" and "worse" or "not worse." The responses "much 
better" and "better" were considered clinically relevant "improve-
ment" consistent with other studies.14–17 All other responses 
were considered "not improved." The responses "slightly worse," 
"worse," and "much worse" were all considered worsening of the 
condition and dichotomized as "worse." All other responses were 
"not worse."14–17 The responses "slightly better" and "unchanged" 
were categorized as "unchanged.
The NRS is graded from 0 (=no pain) to 10 (=unbearable pain), 
where the patient is asked to rate the actual pain in the infil-
trated joint at the time of the specific data collection. Patients 
were required to complete the NRS before the injection while 
in the radiology department (baseline) and both NRS and PGIC 
were recorded at 1 day, 1 week and 1 month after injection. The 
FU NRS and PGIC questionnaires were handed to the patients 
directly after the injection along with a postage pre- paid enve-
lope. Patients were instructed to return the completed question-
naires after the last data collection time point of 1 month.
Statistical analysis
Descriptive statistics were calculated for age and gender of the 
study population and the percentage of pathological MRI find-
ings by each quadrant of the labrum, the bone marrow or the 
articular cartilage. The proportion of patients reporting clinically 
relevant "improvement" (primary outcome) was calculated for 
each of the data collection time points and compared with the 
various MRI abnormalities using the χ2 test. The same analysis 
was done for the proportion of patients reporting worsening of 
their condition. Gender differences for improvement and wors-
ening were also assessed using the χ2 test. ANOVA test and 
Student’s t- tests were used to compare the NRS change scores 
with imaging findings. Logistic regression was performed to 
assess the impact of patient sex, age and baseline pain scores on 
"improvement" at each data collection time point. The χ2 test was 
also used to compare the proportion of patients "improved" or 
"worse" between the patients having routine MRI vs MR arthro-
grams for each data collection time point.
The statistical analyzes were done using the SPSS statistics 
program (v. 21, IBM, Armonk, NY).
results
From the original sample of 114 patients, a total of 100 patients 
(33 males and 67 females) met the inclusion criteria. Of these, 67 
Figure 5. Intra- articular hip infiltration under fluoroscopic 
guidance.
Figure 6. The two outcome measures used for this study: The NRS and the PGIC. NRS, Numerical Rating Scale; PGIC, Patient’s 
Global Impression of Change.
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patients had MR arthrography and 33 had MR without contrast. 
The mean (±SD) age of the cohort was 52.2 (±10.52) years and 
there was no significant age difference between the genders (p = 
0.91).
The baseline mean NRS score (±SD) for all patients was 5.81 
(±2.1), and the 15 min mean NRS score was 3.51 (±2.60) with 
no significant gender differences (p = 0.93). There were also no 
gender differences for the NRS scores at all FU time points (p > 
0.38).
The proportion of patients with the various MRI abnormalities 
by quadrant is shown in Table 2. Articular cartilage and labral 
abnormalities were most common in the anterosuperior quad-
rant, with 63% of patients having both labral degeneration and a 
tear in this region. 41% of patients had articular cartilage lesions 
in the anterosuperior quadrant on the acetabular side of the joint 
(21% with greater than 50% thickness) and 30% had damage in 
the anterosuperior quadrant on the femoral side of the joint (14% 
with greater than 50% thickness). The vast majority of patients 
had no bone marrow edema or subchondral cyst, either in the 
acetabulum or the femoral head.
Table 3 shows the proportion of patients "improved" or "worse" at 
each of the two data collection time points. There was no signif-
icant age difference in the proportion of patients "improved" 
or "worse" for any of the data collection time points (p > 0.15). 
However, there was a significant gender difference in the propor-
tion of patients "worse" at 1 month. For male patients 31.3% (n 
= 10/32) reported being "worse" compared to 8.9% (n = 6/67) 
of the female patients (p = 0.012). Because males had a signifi-
cantly higher proportion of patients reporting "worsening" at 
the 1 month time point, post- hoc analysis compared sex of the 
patients with the various MRI abnormalities using the χ2 test. 
Table 2. Percentage of patients with the various MRI findings by quadrant in a defined anatomical region (% within quadrant of 
the anatomical region)
MR finding by anatomical region Localization in quadrant
Anteroinferior Anterosuperior Posterosuperior Posteroinferior
Labrum
No tear 38% 4% 34% 75%
Degeneration 27% 19% 46% 20%
Tear 11% 14% 4% 1%
Degeneration + tear 24% 63% 16% 4%
Acetabular bone marrow
No bone marrow edema 90% 78% 90% 95%
Bone marrow edema 2% 2% 3% 0%
Subchondral cyst 6% 11% 4% 5%
Edema + Subchondral cyst 2% 9% 3% 0%
Femoral bone marrow
No bone marrow edema 96% 87% 86% 95%
Bone marrow edema 2% 4% 7% 4%
Subchondral cyst 2% 5% 3% 1%
Edema + Subchondral cyst 0% 4% 4% 0%
Acetabular articular cartilage
No damage 87% 59% 76% 82%
Damage with ≤50% substance defect of thickness 7% 20% 13% 13%
Damage with >50% substance defect of thickness 6% 21% 11% 5%
Femoral articular cartilage
No damage 88% 70% 78% 82%
Damage with ≤50% substance defect of thickness 7% 16% 12% 11%
Damage with >50% substance defect of thickness 5% 14% 10% 7%
Table 3. Percentage of patients reporting improvement/wors-
ening at each follow- up time point (PGIC, primary outcome)
Improved Worse Unchanged
At 1 day follow- up 31.3% 13.1% 55.6%
At 1 week follow- up 43.4% 8.1% 48.5%
At 1 month follow- up 32.3% 16.2% 51.5%
PGIC, Patient’s Global Impression of Change.
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There was no significant association for any of the abnormalities 
based on sex. Additionally, logistic regression analysis found that 
females were 2.80 times more likely to report clinically relevant 
"improvement" at 1 day (p = .049) and 2.90 times more likely to 
report clinically relevant "improvement" at 1 month (p = .045) 
compared to males. The baseline NRS scores and patient age 
were not related to "improvement" using logistic regression.
Articular cartilage defects and bone marrow abnormalities at MRI 
were not related to overall "improvement." Specifically, there was 
no significant relationship between the proportion of patients 
reporting "improvement" (p ranged from 0.26 to 0.93) or "wors-
ening" at 1 day (p ranged from 0.06 to 0.73) or 1 month (p ranged 
from 0.13 to 0.94 for improvement and 0.07–0.79 for worsening) 
and any of the specific MRI findings in any of the anatomical 
quadrants. However, at 1 week there was a statistically significant 
difference in the proportion of patients reporting "improvement" 
depending on the presence or absence of labral pathologies in 
the posterosuperior quadrant (p = 0.048). Post- hoc analyzes for 
this anatomical region and time point revealed that 55.9% of the 
patients in the "normal labrum"-category improved, 46.7% in the 
"labral degeneration and tear"-category and 37.0% in the "labral 
degeneration alone"-category.
Comparing the NRS change scores for each of the MRI abnor-
malities by quadrant found statistically significant differences 
at all- time points only for labral findings in the anteroinferior 
quadrant (p = 0.0001 at 1 day, 0.007 at 1 week, 0.029 at 1 month). 
Post- hoc unpaired t- tests were then conducted to determine 
which specific labral findings had greater and lesser pain relief, 
showing that patients in the "labral degeneration"-category had 
the highest NRS change scores (i.e. the most pain reduction) and 
those in the "no labral tear"-category had the lowest NRS change 
scores at all three time points (Tables  4–6). Statistically signif-
icant differences were found for the NRS change scores at all 3 
FU- time points only for the combinations of "no labrum tear 
vs labrum degeneration" and "labrum degeneration vs labrum 
degeneration plus tear" (Tables 4–6).
The only other significant NRS change score finding was at 1 day 
FU for bone marrow edema on the acetabular side of the joint in 
the anterosuperior quadrant (p = 0.009). Post- hoc unpaired t- 
tests were then conducted to determine which specific acetabular 
bone marrow pathology had the highest and lowest change score, 
showing that patients in the "edema only"-category (N = 2) had 
the highest NRS change score of 6.0 (SD = 0.71) (i.e. the most 
pain reduction) and patients having no abnormalities at all (N = 
78) had the lowest NRS change score of 1.71 (SD = 2.24).
There were no significant differences between the native MR 
cohort and patients having MR arthrograms in the proportion of 
patients "improved" or "worse" at any data collection time point.
DIscussIon
No MRI findings were related to "improvement" post- injection 
at the 1 month time point. The only MRI finding related to 
"improvement" at any time point occurred at 1 week in that 
patients with a normal labrum in the posterosuperior quadrant 
showed the largest proportion of patients "improved" compared 
to patients with labral degeneration only or in combination with 
a labral tear. The main finding regarding the secondary outcome 
measure of pain reduction was that the "change" in pain- scores 
was significantly different at all 3 FU- time points for the labral 
anteroinferior quadrant. The largest pain reduction was reported 
by patients with labrum degeneration, the smallest by patients 
with a normal labrum. Articular cartilage and bone marrow 
abnormalities showed no association with pain reduction. As 
there were few MRI abnormalities linked to improvement or 
pain reduction, factors other than imaging findings need to be 
investigated, e.g. the placebo effects.
A study on hip injections with anesthetic by Kivlan et al in 
patients with femoroacetabular impingement reported a higher 
percentage of pain relief by patients where acetabular chon-
dral pathologies were detected at hip arthroscopy, regardless of 
their severity.6 These authors affirm that a defect of the labrum 
without additional cartilage damage should not be the cause of 
the patient's pain. Unlike Kivlan et al, our study did not observe 
any significant differences in the proportion of patients reporting 
"improvement" based on the MRI findings of chondral defects. 
However, Kivlan et al did not use corticosteroids in the injectate 
and had a much lower mean patient age (29.9 years) than our 
study (52.2 years). No other studies have found reliable predic-
tors of response to intra- articular corticosteroid injections of the 
hip.18,19
Other studies on intra- articular hip infiltration3–5 have reported 
no negative side- effects or complications resulting from the 
infiltration. In our current study, we observed worsening of the 
pain in 31.3% of the male patients at 1 month compared to only 
8.9% of the female patients. Reasons for this gender discrepancy 
Table 4. Baseline and 15 min NRS scores
Anteroinferior labral abnormality
Baseline NRS score 
(SD)
15 min NRS score 
(SD)
15 min NRS 
change score 
(SD)
No labrum tear (N = 38) 5.43 (1.97) 4.03 (2.67) 1.40 (2.25)
Labrum degeneration (N = 26) 6.53 (1.79) 3.43 (2.91) 3.10 (2.72)
Labrum tear (N = 11) 6.36 (2.26) 2.91 (2.25) 3.45 (2.90)
Labrum degeneration +tear 5.31 (2.50) 3.04 (2.23) 2.27 (2.02)
N = number or patients; NRS = Numerical Rating Scale (for pain);SD, standard deviation.
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are unknown. No serious side- effects such as septic arthritis 
occurred in the cohort studied, however.
One strength of this study is that it is a prospective outcome 
study, using two simple and validated outcome measures.14,15 
Secondly, this study examines three well- defined categories 
of intra- articular hip pathologies in patients over age 40. This 
results in a homogeneous middle age and older patient group 
with degenerative pathologies, excluding growing disorders or 
conditions manifest in younger populations. A third strength is 
that a consensus reading was performed with two highly expe-
rienced musculoskeletal radiologists rather than having only 
one reader or two independent readings to assess reliability. 
Previous work has shown that the inter rater reliability of inter-
preting MRI findings can be highly variable depending upon the 
specific abnormalities.20,21 These disagreements can usually be 
resolved with a consensus reading and discussion between the 
two readers.
The study also has some weaknesses. Our study was limited to 
a FU- time of 1 month. A longer period of time would be prefer-
able. Further, the NRS and PGIC questionnaires were completed 
by the patients at home and returned with the postage pre- paid 
envelope, preventing any influence from the caregiver. Yet, using 
postal questionnaires and relying on patients to remember 
to return them after the 1 month data collection time point is 
another limitation to this study. As reported by Peterson et al,14 
numerous patients fail to return these questionnaires, which 
reduces the number of participants in the study. A recent study22 
on response rate of patients after a lumbar nerve root injection 
showed that only about 24% of the patients returned the FU ques-
tionnaires, with a worse outcome in the non- responder group. In 
the present study, the questionnaires were virtually the same as 
well as the 1 month time frame, suggesting a likely similar ques-
tionnaire response rate and leading to a possibility of response 
bias in a negative way in the present study. Future studies should 
use SMS or email data collection in order to have longer FU time 
points with good patient compliance.
An additional weakness of this study is that nearly one- third 
of the patients did not have arthrography with their hip MRI 
scans. This may result is some small labral tears being missed on 
non- arthrographic MRI and leading to an observational bias of 
abnormal findings and thus, potentially significantly affect the 
results of this study. Indeed, this study shows paradoxically the 
best likelihood of response to an intra articular infiltration in 
patients with a normal labrum, followed by those with a tear or 
degenerative changes. Moreover, a lack of correlation between 
the pain reduction and the articular cartilage and especially 
bone marrow abnormalities such as the presence of edema was 
observed. Nevertheless, the possibility of improvement due to 
successful treatment of synovitis secondary to OA highlights an 
aspect to be studied in future research studies on inflammatory 
changes identified on arthrographic MRI.
It is interesting that two- thirds of the patients in this study 
cohort were female and on first glance, this may be consid-
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hip pain sufferers with similar female/male ratios reported in 
other studies where between 60 and 76% of the cohorts were 
females.23–25 Females were also nearly three times more likely 
to report clinically relevant "improvement" at both 1 day and 
1 month post injection compared to males. Other recent studies 
have found that females were significantly more likely to have 
positive outcomes for both surgical and non- surgical treatments 
for hip pain and OA.26–28 However, none of these previous 
studies evaluated therapeutic hip infiltrations.
Finally, only imaging findings were compared to treatment 
outcomes and no other factors such as abnormal physical exam-
ination findings or specific complaints in the patient history.
conclusIon
No MRI abnormalities were related to overall "improvement" at 
the 1 month time point. Patients with labral degeneration of the 
anteroinferior quadrant had higher levels of pain reduction at 
all- time points. Females were significantly more likely to report 
"improvement" at 1 day and 1 month post injection.
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